activity of su11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastat..
safety, pharmacokinetic, and antitumor activity of su11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
randomized phase iii trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology gr..
comparison of ca-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophospha..
hormone replacement therapy is associated with decreased survival in women with lung cancer
early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease
first-line single agent treatment with gefitinib in patients with advanced non
neuroendocrine neoplasms of the lung: a prognostic spectrum
patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment
factors related to underuse of surveillance mammography among breast cancer survivors
psychological distress in men with breast cancer
successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis
phase iii study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases
salvage radioimmunotherapy with murine iodine-131
low value of [18f]-fluoro-2-deoxy-d-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy
preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenop..
unconventional anticancer agents: a systematic review of clinical trials
impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials
comparable long-term survival after unrelated and hla-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 ..
intensive therapy with growth factor support for patients with ewing tumor metastatic at diagnosis: pediatric oncology group/children's cancer group phase ii study ..
decision making in pediatric oncology: who should take the lead the decisional priority in pediatric oncology model
clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hema..
phase ii study of oral fludarabine phosphate in relapsed indolent b-cell non-hodgkin's lymphoma
radiotherapy as primary treatment for stage ie and iie nasal natural killer/t-cell lymphoma
clinical cancer advances 2005: major research advances in cancer treatment, prevention, and screening―a report from the american society of clinical oncology
impact of vascular endothelial growth factor-a expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic..
vascular endothelial growth factor-d and its receptor vegfr-3: two novel independent prognostic markers in gastric adenocarcinoma
multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors
new muc1 serum immunoassay differentiates pancreatic cancer from pancreatitis
gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation
ezh2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
tumor necrosis factor-
high frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of pten in uveal melanoma
array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large b-cell lymphoma
evaluation of two phosphorylation sites improves the prognostic significance of akt activation in non
prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas
randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study ..
correlates of return to work for breast cancer survivors
assessing brca carrier probabilities in extended families
the use of radiation as a component of breast conservation therapy in national comprehensive cancer network centers
multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of international breast cancer study group trial 15-95
phase ii study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas
postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial
optimox1: a randomized study of folfox4 or folfox7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer―a gercor study
phase ii study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
similar outcomes between african american and non
the effect of race on invasive staging and surgery in non
astragalus-based chinese herbs and platinum-based chemotherapy for advanced non
phase iii clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by th..
select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justifica..
treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated d..
high complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed bcr-abl
comparison between patients with philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib..
long-term risk of cardiovascular disease in 5-year survivors of testicular cancer
risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the childhood cancer survivor study
thromboembolism in hospitalized neutropenic cancer patients